Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShort-Term Debt issuances
Ratios

Cresco Labs (CRLBF) Loans and Notes Receivables (2019 - 2023)

Cresco Labs filings provide 5 years of Loans and Notes Receivables readings, the most recent being $1.4 million for Q4 2023.

  • On a quarterly basis, Loans and Notes Receivables rose 217.9% to $1.4 million in Q4 2023 year-over-year; TTM through Dec 2023 was $1.4 million, a 217.9% increase, with the full-year FY2023 number at $1.4 million, up 217.9% from a year prior.
  • Loans and Notes Receivables hit $1.4 million in Q4 2023 for Cresco Labs, up from $447000.0 in the prior quarter.
  • In the past five years, Loans and Notes Receivables ranged from a high of $2.4 million in Q4 2020 to a low of $447000.0 in Q4 2022.
  • Median Loans and Notes Receivables over the past 5 years was $1.3 million (2021), compared with a mean of $1.3 million.
  • Biggest five-year swings in Loans and Notes Receivables: skyrocketed 278.57% in 2020 and later plummeted 65.93% in 2022.
  • Cresco Labs' Loans and Notes Receivables stood at $644000.0 in 2019, then skyrocketed by 278.57% to $2.4 million in 2020, then crashed by 46.19% to $1.3 million in 2021, then plummeted by 65.93% to $447000.0 in 2022, then skyrocketed by 217.9% to $1.4 million in 2023.
  • The last three reported values for Loans and Notes Receivables were $1.4 million (Q4 2023), $447000.0 (Q4 2022), and $1.3 million (Q4 2021) per Business Quant data.